Companion Animal Drugs Market, By Product Type (Antibiotics, Anti-inflammatory, Parasiticides, Ecto-Parasiticides, Endo-Parasiticides, Heart worm Products, Behavioral Products, Nutritional Products, Skin care Products, Vaccines), By Distribution Channel (

Companion Animal Drugs Market, By Product Type (Antibiotics, Anti-inflammatory, Parasiticides, Ecto-Parasiticides, Endo-Parasiticides, Heart worm Products, Behavioral Products, Nutritional Products, Skin care Products, Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. According to the National Pet Owners Survey in 2017, conducted by American Pet Products Association (APPA), around 68% of the household owns a companion animal or pet in U.S. Companion animal drug include veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics and parasiticides, which are used in the treatment of disease associated with digestive system, immunological system, reproductive system, respiratory, and urinary system. Increasing expenditure on animal healthcare, increasing pet ownership, increasing incidence and prevalence of zoonotic disease, are major driver attributing to the growth of market during the forecasted period.
Key features of the study:
This report provides in-depth analysis of the North America Companion Animal Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the North America Companion Animal Drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The North America Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America Companion Animal Drugs market
Detailed Segmentation:
North America Companion Animal Drugs Market, By Product Type:
Antibiotics
Anti-inflammatory
Parasiticides
Ecto-Parasiticides
Endo-Parasiticides
Heart worm Products
Behavioral Products
Nutritional Products
Skin care Products
Vaccines
North America Companion Animal Drugs Market, By Distribution Channel:
Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
North America Companion Animal Drugs Market, By Region:
U.S.
By Product Type:
Antibiotics
Anti-inflammatory
Parasiticides
Ecto-Parasiticides
Endo-Parasiticides
Heart worm Products
Behavioral Products
Nutritional Products
Skin care Products
Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
Canada
By Product Type:
Antibiotics
Anti-inflammatory
Parasiticides
Ecto-Parasiticides
Endo-Parasiticides
Heart worm Products
Behavioral Products
Nutritional Products
Skin care Products
Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
Company Profiles
Zoetis Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Merck & Co., Inc.
Bayer AG
Eli Lily & Co.
Sanofi
Ceva Santé Animal
Virbac Animal Health
Boehringer Ingelheim GmbH
“*” marked represents similar segmentation in other categories in the respective section.